Titre : Sclérodermie diffuse

Sclérodermie diffuse : Questions médicales fréquentes

Termes MeSH sélectionnés :

Cloud Computing
{ "@context": "https://schema.org", "@graph": [ { "@type": "MedicalWebPage", "name": "Sclérodermie diffuse : Questions médicales les plus fréquentes", "headline": "Sclérodermie diffuse : Comprendre les symptômes, diagnostics et traitements", "description": "Guide complet et accessible sur les Sclérodermie diffuse : explications, diagnostics, traitements et prévention. Information médicale validée destinée aux patients.", "datePublished": "2024-05-29", "dateModified": "2025-02-23", "inLanguage": "fr", "medicalAudience": [ { "@type": "MedicalAudience", "name": "Grand public", "audienceType": "Patient", "healthCondition": { "@type": "MedicalCondition", "name": "Sclérodermie diffuse" }, "suggestedMinAge": 18, "suggestedGender": "unisex" }, { "@type": "MedicalAudience", "name": "Médecins", "audienceType": "Physician", "geographicArea": { "@type": "AdministrativeArea", "name": "France" } }, { "@type": "MedicalAudience", "name": "Chercheurs", "audienceType": "Researcher", "geographicArea": { "@type": "AdministrativeArea", "name": "International" } } ], "reviewedBy": { "@type": "Person", "name": "Dr Olivier Menir", "jobTitle": "Expert en Médecine", "description": "Expert en Médecine, Optimisation des Parcours de Soins et Révision Médicale", "url": "/static/pages/docteur-olivier-menir.html", "alumniOf": { "@type": "EducationalOrganization", "name": "Université Paris Descartes" } }, "isPartOf": { "@type": "MedicalWebPage", "name": "Sclérodermie systémique", "url": "https://questionsmedicales.fr/mesh/D012595", "about": { "@type": "MedicalCondition", "name": "Sclérodermie systémique", "code": { "@type": "MedicalCode", "code": "D012595", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "C17.800.784" } } }, "about": { "@type": "MedicalCondition", "name": "Sclérodermie diffuse", "alternateName": "Scleroderma, Diffuse", "code": { "@type": "MedicalCode", "code": "D045743", "codingSystem": "MeSH" } }, "author": [ { "@type": "Person", "name": "None None", "url": "https://questionsmedicales.fr/author/None%20None", "affiliation": { "@type": "Organization", "name": "" } }, { "@type": "Person", "name": "Dinesh Khanna", "url": "https://questionsmedicales.fr/author/Dinesh%20Khanna", "affiliation": { "@type": "Organization", "name": "Division of Rheumatology, Department of Internal Medicine, University of Michigan, Ann Arbor, MI, USA." } }, { "@type": "Person", "name": "Christopher P Denton", "url": "https://questionsmedicales.fr/author/Christopher%20P%20Denton", "affiliation": { "@type": "Organization", "name": "UCL Division of Medicine, Royal Free Campus, London, UK." } }, { "@type": "Person", "name": "Ami A Shah", "url": "https://questionsmedicales.fr/author/Ami%20A%20Shah", "affiliation": { "@type": "Organization", "name": "Division of Rheumatology, Johns Hopkins University School of Medicine, 5200 Eastern Avenue, Mason F. Lord Building, Center Tower, Suite 4100, Baltimore, MD 21224, USA. Electronic address: Ami.Shah@jhmi.edu." } }, { "@type": "Person", "name": "Susanna Proudman", "url": "https://questionsmedicales.fr/author/Susanna%20Proudman", "affiliation": { "@type": "Organization", "name": "Rheumatology Unit, Royal Adelaide Hospital, Adelaide, South Australia, Australia." } } ], "citation": [ { "@type": "ScholarlyArticle", "name": "Photon Counting Computed Tomography for Accurate Cribriform Plate (Lamina Cribrosa) Imaging in Adult Patients.", "datePublished": "2024-03-08", "url": "https://questionsmedicales.fr/article/38535773", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.3390/tomography10030031" } }, { "@type": "ScholarlyArticle", "name": "Experimental Structures of Antibody/MHC-I Complexes Reveal Details of Epitopes Overlooked by Computational Prediction.", "datePublished": "2024-03-08", "url": "https://questionsmedicales.fr/article/38456672", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.4049/jimmunol.2300839" } }, { "@type": "ScholarlyArticle", "name": "bacLIFE: a user-friendly computational workflow for genome analysis and prediction of lifestyle-associated genes in bacteria.", "datePublished": "2024-03-07", "url": "https://questionsmedicales.fr/article/38453959", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1038/s41467-024-46302-y" } }, { "@type": "ScholarlyArticle", "name": "Computer vision syndrome among Sudanese medical students: a growing medical issue in the digital world.", "datePublished": "2024-03-06", "url": "https://questionsmedicales.fr/article/38694278", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1097/MS9.0000000000001917" } }, { "@type": "ScholarlyArticle", "name": "Applying Proteomics and Computational Approaches to Identify Novel Targets in Blast-Associated Post-Traumatic Epilepsy.", "datePublished": "2024-03-01", "url": "https://questionsmedicales.fr/article/38474127", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.3390/ijms25052880" } } ], "breadcrumb": { "@type": "BreadcrumbList", "itemListElement": [ { "@type": "ListItem", "position": 1, "name": "questionsmedicales.fr", "item": "https://questionsmedicales.fr" }, { "@type": "ListItem", "position": 2, "name": "Maladies de la peau et du tissu conjonctif", "item": "https://questionsmedicales.fr/mesh/D017437" }, { "@type": "ListItem", "position": 3, "name": "Maladies de la peau", "item": "https://questionsmedicales.fr/mesh/D012871" }, { "@type": "ListItem", "position": 4, "name": "Sclérodermie systémique", "item": "https://questionsmedicales.fr/mesh/D012595" }, { "@type": "ListItem", "position": 5, "name": "Sclérodermie diffuse", "item": "https://questionsmedicales.fr/mesh/D045743" } ] } }, { "@type": "MedicalWebPage", "name": "Article complet : Sclérodermie diffuse - Questions et réponses", "headline": "Questions et réponses médicales fréquentes sur Sclérodermie diffuse", "description": "Une compilation de questions et réponses structurées, validées par des experts médicaux.", "datePublished": "2025-05-11", "inLanguage": "fr", "hasPart": [ { "@type": "MedicalWebPage", "name": "Diagnostic", "headline": "Diagnostic sur Sclérodermie diffuse", "description": "Comment diagnostiquer la sclérodermie diffuse ?\nQuels tests sanguins sont utilisés ?\nLes biopsies cutanées sont-elles nécessaires ?\nQuels signes cliniques sont observés ?\nLa radiographie est-elle utile dans le diagnostic ?", "url": "https://questionsmedicales.fr/mesh/D045743?mesh_terms=Cloud+Computing&page=998#section-diagnostic" }, { "@type": "MedicalWebPage", "name": "Symptômes", "headline": "Symptômes sur Sclérodermie diffuse", "description": "Quels sont les symptômes principaux ?\nLa fatigue est-elle un symptôme courant ?\nY a-t-il des symptômes respiratoires ?\nComment se manifeste l'atteinte digestive ?\nLes troubles vasculaires sont-ils fréquents ?", "url": "https://questionsmedicales.fr/mesh/D045743?mesh_terms=Cloud+Computing&page=998#section-symptômes" }, { "@type": "MedicalWebPage", "name": "Prévention", "headline": "Prévention sur Sclérodermie diffuse", "description": "Peut-on prévenir la sclérodermie diffuse ?\nQuels facteurs de risque sont identifiés ?\nLe tabagisme influence-t-il la maladie ?\nL'exposition au froid est-elle un risque ?\nLes infections peuvent-elles aggraver la maladie ?", "url": "https://questionsmedicales.fr/mesh/D045743?mesh_terms=Cloud+Computing&page=998#section-prévention" }, { "@type": "MedicalWebPage", "name": "Traitements", "headline": "Traitements sur Sclérodermie diffuse", "description": "Quels traitements sont disponibles ?\nLes corticostéroïdes sont-ils efficaces ?\nQuelles thérapies physiques sont recommandées ?\nY a-t-il des traitements expérimentaux ?\nComment gérer les symptômes cutanés ?", "url": "https://questionsmedicales.fr/mesh/D045743?mesh_terms=Cloud+Computing&page=998#section-traitements" }, { "@type": "MedicalWebPage", "name": "Complications", "headline": "Complications sur Sclérodermie diffuse", "description": "Quelles sont les complications possibles ?\nLa sclérodermie peut-elle affecter le cœur ?\nY a-t-il un risque d'infections ?\nComment la sclérodermie affecte-t-elle les reins ?\nLes complications digestives sont-elles fréquentes ?", "url": "https://questionsmedicales.fr/mesh/D045743?mesh_terms=Cloud+Computing&page=998#section-complications" }, { "@type": "MedicalWebPage", "name": "Facteurs de risque", "headline": "Facteurs de risque sur Sclérodermie diffuse", "description": "Quels sont les principaux facteurs de risque ?\nL'âge joue-t-il un rôle ?\nLes facteurs environnementaux sont-ils significatifs ?\nY a-t-il un lien avec d'autres maladies auto-immunes ?\nLe stress peut-il aggraver la maladie ?", "url": "https://questionsmedicales.fr/mesh/D045743?mesh_terms=Cloud+Computing&page=998#section-facteurs de risque" } ] }, { "@type": "FAQPage", "mainEntity": [ { "@type": "Question", "name": "Comment diagnostiquer la sclérodermie diffuse ?", "position": 1, "acceptedAnswer": { "@type": "Answer", "text": "Le diagnostic repose sur l'examen clinique, les antécédents médicaux et des tests sanguins." } }, { "@type": "Question", "name": "Quels tests sanguins sont utilisés ?", "position": 2, "acceptedAnswer": { "@type": "Answer", "text": "Les tests incluent la recherche d'anticorps spécifiques comme les anticorps anti-Scl-70." } }, { "@type": "Question", "name": "Les biopsies cutanées sont-elles nécessaires ?", "position": 3, "acceptedAnswer": { "@type": "Answer", "text": "Elles peuvent être réalisées pour évaluer l'atteinte tissulaire et confirmer le diagnostic." } }, { "@type": "Question", "name": "Quels signes cliniques sont observés ?", "position": 4, "acceptedAnswer": { "@type": "Answer", "text": "Les signes incluent un durcissement de la peau, des œdèmes et des troubles vasculaires." } }, { "@type": "Question", "name": "La radiographie est-elle utile dans le diagnostic ?", "position": 5, "acceptedAnswer": { "@type": "Answer", "text": "Oui, elle peut aider à évaluer les atteintes pulmonaires ou digestives associées." } }, { "@type": "Question", "name": "Quels sont les symptômes principaux ?", "position": 6, "acceptedAnswer": { "@type": "Answer", "text": "Les symptômes incluent un durcissement de la peau, des douleurs articulaires et des troubles digestifs." } }, { "@type": "Question", "name": "La fatigue est-elle un symptôme courant ?", "position": 7, "acceptedAnswer": { "@type": "Answer", "text": "Oui, la fatigue est fréquente et peut être liée à l'inflammation et à l'atteinte organique." } }, { "@type": "Question", "name": "Y a-t-il des symptômes respiratoires ?", "position": 8, "acceptedAnswer": { "@type": "Answer", "text": "Oui, des difficultés respiratoires peuvent survenir en raison de l'atteinte pulmonaire." } }, { "@type": "Question", "name": "Comment se manifeste l'atteinte digestive ?", "position": 9, "acceptedAnswer": { "@type": "Answer", "text": "Elle peut se traduire par des reflux, des troubles de la déglutition et des douleurs abdominales." } }, { "@type": "Question", "name": "Les troubles vasculaires sont-ils fréquents ?", "position": 10, "acceptedAnswer": { "@type": "Answer", "text": "Oui, des phénomènes de Raynaud et des ulcères digitaux peuvent se produire." } }, { "@type": "Question", "name": "Peut-on prévenir la sclérodermie diffuse ?", "position": 11, "acceptedAnswer": { "@type": "Answer", "text": "Il n'existe pas de méthode de prévention connue, mais éviter les facteurs de risque peut aider." } }, { "@type": "Question", "name": "Quels facteurs de risque sont identifiés ?", "position": 12, "acceptedAnswer": { "@type": "Answer", "text": "Les facteurs incluent des antécédents familiaux, des expositions environnementales et le sexe féminin." } }, { "@type": "Question", "name": "Le tabagisme influence-t-il la maladie ?", "position": 13, "acceptedAnswer": { "@type": "Answer", "text": "Oui, le tabagisme peut aggraver les symptômes et augmenter le risque de complications." } }, { "@type": "Question", "name": "L'exposition au froid est-elle un risque ?", "position": 14, "acceptedAnswer": { "@type": "Answer", "text": "Oui, l'exposition au froid peut déclencher des symptômes vasculaires comme le phénomène de Raynaud." } }, { "@type": "Question", "name": "Les infections peuvent-elles aggraver la maladie ?", "position": 15, "acceptedAnswer": { "@type": "Answer", "text": "Certaines infections peuvent exacerber les symptômes et compliquer la gestion de la maladie." } }, { "@type": "Question", "name": "Quels traitements sont disponibles ?", "position": 16, "acceptedAnswer": { "@type": "Answer", "text": "Les traitements incluent des immunosuppresseurs, des anti-inflammatoires et des thérapies symptomatiques." } }, { "@type": "Question", "name": "Les corticostéroïdes sont-ils efficaces ?", "position": 17, "acceptedAnswer": { "@type": "Answer", "text": "Ils peuvent réduire l'inflammation, mais leur utilisation doit être prudente en raison des effets secondaires." } }, { "@type": "Question", "name": "Quelles thérapies physiques sont recommandées ?", "position": 18, "acceptedAnswer": { "@type": "Answer", "text": "La kinésithérapie peut aider à maintenir la mobilité et à réduire la douleur articulaire." } }, { "@type": "Question", "name": "Y a-t-il des traitements expérimentaux ?", "position": 19, "acceptedAnswer": { "@type": "Answer", "text": "Des traitements comme les inhibiteurs de la tyrosine kinase sont en cours d'évaluation." } }, { "@type": "Question", "name": "Comment gérer les symptômes cutanés ?", "position": 20, "acceptedAnswer": { "@type": "Answer", "text": "Des crèmes hydratantes et des traitements topiques peuvent aider à soulager les symptômes cutanés." } }, { "@type": "Question", "name": "Quelles sont les complications possibles ?", "position": 21, "acceptedAnswer": { "@type": "Answer", "text": "Les complications incluent des atteintes pulmonaires, cardiaques et rénales, ainsi que des troubles digestifs." } }, { "@type": "Question", "name": "La sclérodermie peut-elle affecter le cœur ?", "position": 22, "acceptedAnswer": { "@type": "Answer", "text": "Oui, elle peut entraîner des arythmies, une hypertension pulmonaire et une insuffisance cardiaque." } }, { "@type": "Question", "name": "Y a-t-il un risque d'infections ?", "position": 23, "acceptedAnswer": { "@type": "Answer", "text": "Oui, les patients peuvent être plus susceptibles aux infections en raison d'une immunité altérée." } }, { "@type": "Question", "name": "Comment la sclérodermie affecte-t-elle les reins ?", "position": 24, "acceptedAnswer": { "@type": "Answer", "text": "Elle peut provoquer une hypertension rénale et une insuffisance rénale, nécessitant une surveillance." } }, { "@type": "Question", "name": "Les complications digestives sont-elles fréquentes ?", "position": 25, "acceptedAnswer": { "@type": "Answer", "text": "Oui, elles incluent des reflux, des troubles de la motilité et des malabsorption." } }, { "@type": "Question", "name": "Quels sont les principaux facteurs de risque ?", "position": 26, "acceptedAnswer": { "@type": "Answer", "text": "Les antécédents familiaux, le sexe féminin et certaines expositions environnementales sont des facteurs de risque." } }, { "@type": "Question", "name": "L'âge joue-t-il un rôle ?", "position": 27, "acceptedAnswer": { "@type": "Answer", "text": "Oui, la sclérodermie diffuse survient généralement entre 30 et 50 ans, mais peut toucher d'autres âges." } }, { "@type": "Question", "name": "Les facteurs environnementaux sont-ils significatifs ?", "position": 28, "acceptedAnswer": { "@type": "Answer", "text": "Oui, l'exposition à des solvants organiques et à la silice peut augmenter le risque." } }, { "@type": "Question", "name": "Y a-t-il un lien avec d'autres maladies auto-immunes ?", "position": 29, "acceptedAnswer": { "@type": "Answer", "text": "Oui, les personnes ayant d'autres maladies auto-immunes peuvent avoir un risque accru." } }, { "@type": "Question", "name": "Le stress peut-il aggraver la maladie ?", "position": 30, "acceptedAnswer": { "@type": "Answer", "text": "Le stress peut exacerber les symptômes, bien que son rôle exact dans la sclérodermie ne soit pas clair." } } ] } ] }

Sources (10000 au total)

Prevalence of computer vision syndrome during the COVID-19 pandemic: a systematic review and meta-analysis.

Computer vision syndrome has become a significant public health problem, especially in developing countries. Therefore, this study aims to identify the prevalence of computer vision syndrome during th... A systematic review and meta-analysis of the literature was conducted using the databases PubMed, Scopus, Web of Science, and Embase up to February 22, 2023, using the search terms "Computer Vision Sy... A total of 192 studies were retrieved, of which 18 were included in the final meta-analysis. The total sample included 10,337 participants from 12 countries. The combined prevalence of computer vision... According to the study, 74% of the participants experienced computer vision syndrome during the COVID-19 pandemic. Given this finding, it is essential to implement preventive and therapeutic measures ... The protocol for this systematic review and meta-analysis was registered in the international registry of systematic reviews, the International Prospective Register of Systematic Reviews (PROSPERO), w...

Spectral computed tomography angiography using a gadolinium-based contrast agent for imaging of pathologies of the aorta.

Especially patients with aortic aneurysms and multiple computed tomography angiographies (CTA) might show medical conditions which oppose the use of iodine-based contrast agents. CTA using monoenerget... Twenty-one consecutive scans in 15 patients with and without endovascular aneurysm repair showing contraindications for iodine-based contrast agents were examined using clinical routine doses (0.2 mmo... There was a significant increase in the intravascular attenuation of the aorta between pre- and post-contrast images for the MonoE40 images in the thoracic and the abdominal aorta (p < 0.001 for both)... To conclude, our study showed that Gd-CTA is a valid and reliable alternative for diagnostic imaging of the aorta for clinical applications. Monoenergetic reconstructions of computed tomography angiog...

Evaluation of Interstitial Lung Diseases with Deep Learning Method of Two Major Computed Tomography Patterns.

Interstitial lung diseases (ILD) encompass various disorders characterized by inflammation and/or fibrosis in the lung interstitium. These conditions produce distinct patterns in High-Resolution Compu... We employ a deep learning method to diagnose the most commonly encountered patterns in ILD differentially.... Patients were categorized into usual interstitial pneumonia (UIP), nonspecific interstitial pneumonia (NSIP), and normal lung parenchyma groups. VGG16 and VGG19 deep learning architectures were utiliz... The success of the VGG16 model in the test phase was 95.02% accuracy. Using the same data, 98.05% accuracy results were obtained in the test phase of the VGG19 model.... Deep Learning models showed high accuracy in distinguishing the two most common patterns of ILD....